高级检索
当前位置: 首页 > 详情页

Bidirectional Regulation of Manganese Superoxide Dismutase (MnSOD) on the Radiosensitivity of Esophageal Cancer Cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Chemoradiotherapy, Tangshan People’s Hospital [2]Department of Radiotherapy, The Military General Hospital of Beijing PLA, Beijing, [3]Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [4]Department of Endocrinology, Tangshan Workers Hospital, Tangshan,
出处:
ISSN:

关键词: Manganese superoxide dismutase nitric oxide esophageal carcinoma reactive oxygen species

摘要:
The mitochondrial antioxidant protein manganese superoxide dismutase (MnSOD) may represent a new type of tumor suppressor protein. Overexpression of the cDNA of this gene by plasmid or recombinant lentiviral transfection in various types of cancer leads to growth suppression both in vitro and in vivo. We previously determined that changes in MnSOD expression had bidirectional effects on adriamycin (ADR) when combined with nitric oxide (NO). Radiation induces free radicals in a manner similar to ADR, so we speculated that MnSOD combined with NO would also have a bidirectional effect on cellular radiosensitivity. To examine this hypothesis, TE-1 human esophageal squamous carcinoma cells were stably transfected using lipofectamine with a pLenti6-DEST plasmid containing human MnSOD cDNA at moderate to high overexpression levels or with no MnSOD insert. Blastidicin-resistant colonies were isolated, grown, and maintained in culture. We found that moderate overexpression of MnSOD decreased growth rates, plating efficiency, and increased apoptosis. However, high overexpression increased growth rates, plating efficiency, and decreased apoptosis. When combined with NO, moderate overexpression of MnSOD increased the radiosensitivity of esophageal cancer cells, whereas high MnSOD overexpression had the opposite effect. This finding suggests a potential new method to kill certain radioresistant tumors and to provide radioresistance to normal cells.

基金:

基金编号: 30 540 005

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
JCR分区:
出版当年[2012]版:
Q4 ONCOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Department of Chemoradiotherapy, Tangshan People’s Hospital
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号